Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

209 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Antiviral activity and safety of aplaviroc, a CCR5 antagonist, in combination with lopinavir/ritonavir in HIV-infected, therapy-naïve patients: results of the EPIC study (CCR100136).
Yeni P, Lamarca A, Berger D, Cimoch P, Lazzarin A, Salvato P, Smaill FM, Teofilo E, Madison SJ, Nichols WG, Adkison KK, Bonny T, Millard J, McCarty D; EPIC (CCR100136) study team. Yeni P, et al. Among authors: millard j. HIV Med. 2009 Feb;10(2):116-24. doi: 10.1111/j.1468-1293.2008.00660.x. HIV Med. 2009. PMID: 19200175 Free article. Clinical Trial.
Hepatotoxicity observed in clinical trials of aplaviroc (GW873140).
Nichols WG, Steel HM, Bonny T, Adkison K, Curtis L, Millard J, Kabeya K, Clumeck N. Nichols WG, et al. Among authors: millard j. Antimicrob Agents Chemother. 2008 Mar;52(3):858-65. doi: 10.1128/AAC.00821-07. Epub 2007 Dec 10. Antimicrob Agents Chemother. 2008. PMID: 18070967 Free PMC article. Clinical Trial.
A 42-week open-label study to assess the pharmacokinetics, antiretroviral activity, and safety of amprenavir or amprenavir plus ritonavir in combination with abacavir and lamivudine for treatment of HIV-infected patients.
Wood R, Eron J, Arasteh K, Teofilo E, Trepo C, Livrozet JM, Yeo J, Millard J, Wire MB, Naderer OJ. Wood R, et al. Among authors: millard j. Clin Infect Dis. 2004 Aug 15;39(4):591-4. doi: 10.1086/422452. Epub 2004 Jul 26. Clin Infect Dis. 2004. PMID: 15356829 Clinical Trial.
Six-week randomized controlled trial to compare the tolerabilities, pharmacokinetics, and antiviral activities of GW433908 and amprenavir in human immunodeficiency virus type 1-infected patients.
Wood R, Arasteh K, Stellbrink HJ, Teofilo E, Raffi F, Pollard RB, Eron J, Yeo J, Millard J, Wire MB, Naderer OJ. Wood R, et al. Among authors: millard j. Antimicrob Agents Chemother. 2004 Jan;48(1):116-23. doi: 10.1128/AAC.48.1.116-123.2004. Antimicrob Agents Chemother. 2004. PMID: 14693528 Free PMC article. Clinical Trial.
The NEAT study: a 48-week open-label study to compare the antiviral efficacy and safety of GW433908 versus nelfinavir in antiretroviral therapy-naive HIV-1-infected patients.
Rodriguez-French A, Boghossian J, Gray GE, Nadler JP, Quinones AR, Sepulveda GE, Millard JM, Wannamaker PG. Rodriguez-French A, et al. Among authors: millard jm. J Acquir Immune Defic Syndr. 2004 Jan 1;35(1):22-32. doi: 10.1097/00126334-200401010-00003. J Acquir Immune Defic Syndr. 2004. PMID: 14707788 Clinical Trial.
A dose-ranging study to evaluate the antiretroviral activity and safety of amprenavir alone and in combination with abacavir in HIV-infected adults with limited antiretroviral experience.
Schooley RT, Clumeck N, Haubrich R, Thompson M, Danner SA, van Der Ende ME, Sereni D, Antunes F, Blake D, Myers RE, Tisdale M, Millard J, Mustafa N, Nacci P. Schooley RT, et al. Among authors: millard j. Antivir Ther. 2001 Jun;6(2):89-96. Antivir Ther. 2001. PMID: 11491421 Clinical Trial.
Zidovudine in persons with asymptomatic HIV infection and CD4+ cell counts greater than 400 per cubic millimeter. The European-Australian Collaborative Group.
Cooper DA, Gatell JM, Kroon S, Clumeck N, Millard J, Goebel FD, Bruun JN, Stingl G, Melville RL, González-Lahoz J, et al. Cooper DA, et al. Among authors: millard j. N Engl J Med. 1993 Jul 29;329(5):297-303. doi: 10.1056/NEJM199307293290501. N Engl J Med. 1993. PMID: 8100611 Free article. Clinical Trial.
209 results